EFTA01584264.pdf

r -- i Any instructions received after the above time on the JPMorgan Response Due Date will be processed on a "reasonable endeavors" basis only. execution ofthe instruction cannot be guaranteed This information is distributed with the understanding that it is not rendering investment, legal or tax advice. As your custodian, we have not reviewed the offer and make no recommendations as to this offer. You arc not required to accept the offer. Please consult an investment advisor, attorney or tax professional concerning such matters. Teems "TIME CRITICAL EVENT" ISSUE TYPE : CONSENT SOLICITATION ASSET NAME : BRASKEM FINANCE LT ASSET DESCRIPTION : 7.37SPCT BDS 04/OCT/2015 USDI 000 SEDOUASSET ID: B3W1X06 ISIN CODE : US10553YAC93 CONSENT FEE PAID: USD I FOR 1,000 NOMINAL RECORD DATE : 04 APR 2012 CONSENT PERIOD : 06 APR 2012 TO 16 APR 2012 CONSENT DETAIL: PURPOSE OF THE EVENT: THE ISSUER IS REQUESTING HOLDERS TO CONSENT TO THE PROPOSED AMENDMENTS. IF THE APPLICABLE SUPPLEMENTAL INDENTURE IS EXECUTED AND THE OTHER TERMS AND CONDITIONS SET FORTH IN THIS SOLICITATION STATEMENT ARE SATISFIED OR WAIVED, THEN HOLDERS WILL RECEIVE A CASH PAYMENT EQUAL TO USD 1.00 PER USD 1,000 PRINCIPAL AMOUNT OF SUCH SECURITIES IN RESPECT OF WHICH SUCH CONSENT LETTERS AND CONSENTS TO THE APPLICABLE PROPOSED AMENDMENTS HAVE BEEN VALIDLY DELIVERED AND NOT VALIDLY REVOKED. DOCUMENTATION WILL BE MADE AVAILABLE VIA SEPERATE EMAIL. The client is solely and exclusively responsible for knowing the rights and terms of all securities owned by the client, specifically including valuable rights that may expire unless the client take action. This includes, but is not limited to, warrants, stock rights, convertible securities, bonds, and securities subject to a tender or exchange offer. Accordingly, any oral or electronic information or interpretation provided by J.P. Morgan is subject to the written rights and terms as promulgated by the issuer or applicable law and regulation, and J.P. Morgan is not responsible for any discrepancies therewith. J.P. Morgan is not obligated to take any action or render any advice with respect to the voting of proxies or other corporate actions related to securities owned by a client 2 Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00064119 EFTA01584264